ERN1 and Insulin resistance: PERK transiently inhibits eukaryotic initiation factor (EIF-2α) through phosphorylation, while IRE1 triggers other cell fate signalling pathways, such as c-Jun N-terminal kinase (JNK) that is also a central mediator of insulin signalling and implicated in insulin resistance [7, 14].